Medicinal product name Ezaprev 0.088 mg tablets
Pharmaceutical form Tablet
Strength 0.088 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Package leafletMS Word document 01-02-2018
Summary of product characteristicsMS Word document 01-02-2018
ATC code N04BC05 Anti-parkinson drugs

Important notice

Additional information regarding the use for persons aged 75+

If used as "ANTI-PARKINSON DRUGS"
SubstanceClassComment
PramipexolumCSuitable for older persons, with specific cautions. Sedative. Start therapy under specialist supervision. Reduce the dose in even moderate renal insufficiency. The most common adverse effects are orthostatic hypotension, gastrointestinal symptoms, drowsiness, hallucinations, confusion and sudden bouts of falling asleep. Take interactions into account, especially with antipsychotics.

Medicinal products (3)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(0,088 mg)
PA/Al/PVC/Al blister 2.20  09-0159-01 Labelling text Labelling text Feb 1, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(0,088 mg)
PA/Al/PVC/Al blister    09-0159-02 Labelling text Labelling text Feb 1, 2018
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(0,088 mg)
PA/Al/PVC/Al blister    09-0159-03 Labelling text Labelling text Feb 1, 2018

Registration information

Marketing authorisation No. 09-0159
MA suspended from the medicinal product register by request of Norameda UAB, Lithuania Mar 14, 2023
Permitted to distribute until Sep 14, 2023
Marketing authorisation holder, country Norameda UAB, Lithuania